3ANTONIUCCI D, RODRIGUEZ A, HEMPEL A, et al. A randomized trial comparing primary infarct ar- tery stenting with or without abciximab in acute myo- cardial infaretion[J]. J Am Coll Cardiol, 2003, 42: 1879-1885.
4WOHRLE J,GREBE O C,NUSSER T,et al. Reduc- tion of major adverse cardiac events with intraeoro- nary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty [J]. Circulation, 2003,107 : 1840-1843.
5WU T G,ZHAO Q,HUANG W G,et al. Effect of in traeoronary tirofiban in patients undergoing percuta neous coronary intervention for acute coronary syn drome[J]. Cire J, 2008,72 : 1605 - 1609.
6STONE G W,GRINES C L,COX D A,et al. For the CADILLAC Investigators. Comparison of angioplasty with stenting, with or without ahciximab, in acute my- ocardial infarction[J]. N Engl J Med, 2002,346:957 -966.
7I.EE D P,HERITY N A,HIAT B L,et al. Adjunctive platelet glycoprotein IIb/IIIa receptor inhibition with tirofiban before primary angioplasty improves angio- graphic outcomes: Results of the Tirofiban Given in the Emergency Room before Primary Angiopiasty (TIGER-PA) Pilot Trial [J ]. Circulation, 2003, 107 : 1497-1501.
8VALGIMIGLI M, CAMPO G, PERCOCO G, et al. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus elu- ting or uncoated stents for acute myocardial infarc- tion:The MULTISTRATEGY Randomized Trial[J]. JAMA, 2008,299 : 1788- 1799.
9MARZOCCHI A, MANARI A, PIOVACCARI G, et al. For the FATA investigators. Randomized compari- son between tirofiban and abciximab to promote com- plete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abciximab (FATA) in ST-elevation myocardial infarction trial [J]. Eur Heart J,2008,29:2972-2980.
10TAGLIERI N,SAIA F,GUIDUCCI V, et al. For the FATA investigators. Left ventricular function after ST eleva-tion myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban(from the facilitated angioplasty with tirofiban or abciximab [FATA] trial)[J]. Am J Cardiol, 2009,103 : 785- 790.
